TRETINOIN | A202209 | ALLERGAN SALES LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Matawan Pharmaceuticals, LLC FDA-2015-P-1903 Matawan Pharmaceuticals, LLC submitted a suitability petition on May 26, 2015, pursuant to 21 C.F.R. § 10.30 and Section 502(j)(2)(c) of the Federal Food, Drug, and Cosmetic Act, requesting that the FDA Commissioner declare tretinoin cream in strengths of 0.0435% and 0.0625% suitable for considerati | Other | 2015-05-29 | Open | Matawan Pharmaceuticals |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.